ORION OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.09 EUR | -1.57% |
|
+3.11% | -5.55% |
| 05-07 | Orion Corporation Announces Change in Orion Group Executive Management Board as of 31 May 2025 | CI |
| 04-26 | Orion Corporation Announces Appointments to Nomination Committee | CI |
ETFs positioned on Orion Oyj
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.96% | 664 M€ | +11.18% | ||
| 2.87% | 473 M€ | +6.07% | ||
| 0.35% | 1,083 M€ | +3.59% | ||
| 0.32% | 3 M€ | +9.95% | - | |
| 0.24% | 2 M€ | +11.01% | ||
| 0.14% | 5 M€ | +10.09% | - | |
| 0.14% | 14 M€ | +5.66% | - | |
| 0.12% | 17 M€ | +4.55% | - | |
| 0.11% | 17 M€ | +6.60% | - | |
| 0.07% | 6 M€ | -.--% | - | |
| 0.03% | 6 M€ | -.--% | ||
| 0.02% | 10 M€ | -3.35% | - | |
| 0.02% | 187 M€ | +9.15% | - | |
| 0.02% | 264 M€ | -.--% | - | |
| 0.02% | 477 M€ | +11.46% | ||
| 0.02% | 276 M€ | +11.40% | - | |
| 0.01% | 607 M€ | +0.05% | ||
| 0.01% | 1,166 M€ | +0.26% | ||
| 0.01% | 391 M€ | +8.67% | - | |
| 0.01% | 284 M€ | -.--% | ||
| 0.01% | 283 M€ | +19.00% | ||
| 0.01% | 206 M€ | -.--% | ||
| 0.01% | 45 M€ | 0.00% | - | |
| 0.01% | 105 M€ | +3.54% | - | |
| 0.01% | 34 M€ | +8.24% | - |
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
Pharmaceuticals
Calendar
2024-08-08
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
37.68
EUR
Average target price
39
EUR
Spread / Average Target
+3.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.55% | 5.7B | |
| +29.45% | 684B | |
| +30.34% | 568B | |
| -3.95% | 361B | |
| +17.56% | 329B | |
| +4.14% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +6.91% | 166B |
- Stock Market
- Equities
- ORNBV Stock
- Funds and ETFs Orion Oyj
